Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of tetrasodium 8,8'-(1E,1'E)-(4,4'-(cyclohexane-1,1-diyl)bis(4,1-phenylene))bis(diazene-2,1-diyl)bis(7-hydroxynaphthalene-1,3-disulfonate) and trisodium 7-hydroxy-8-((E)-(4-(1-(4-((E)-(1-hydroxy-4-sulfonatonaphthalen-2-yl)diazenyl)phenyl)cyclohexyl)phenyl)diazenyl)naphthalene-1,3-disulfonate
EC number: 942-692-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- other: read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- constituent 1
- Adequacy of study:
- key study
- Study period:
- From January 24th to March 24th, 1994
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Remarks:
- The complete Read Across Approach is attached at section 13. Source study has reliability 1.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- (1992)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A LLNA study has not been conducted because adequate data from guinea pig Maximisation Test study was already available.
Test material
- Reference substance name:
- Similar Substance 01
- IUPAC Name:
- Similar Substance 01
- Test material form:
- solid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Strain: white.
- Breeder: Ciba-Geigy Ltd. Animal Production Stein.
- Weight at study initiation: between 300 to 433 g.
- Housing: the animals were housed individually in Macrolon cages (Type 3).
- Diet: standard guinea pig pellets -NAFAG No. 845, ad libitum.
- Water: ad libitum.
- Acclimation: 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C
- Humidity: 30 to 70 %
- Photoperiod: 12 hours light cycle day.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: physiological saline
- Concentration / amount:
- 5 % of test item
- Route:
- epicutaneous, occlusive
- Vehicle:
- petrolatum
- Remarks:
- vaseline
- Concentration / amount:
- 50 % of test item
- Day(s)/duration:
- 48 hours
- Adequacy of induction:
- highest technically applicable concentration used
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- petrolatum
- Remarks:
- vaseline
- Concentration / amount:
- 10 % of test item
- Day(s)/duration:
- 24 hours
- No. of animals per dose:
- CONTROL GROUP: 5 males and 5 females
TEST GROUP: 10 males and 10 females main experiment. - Details on study design:
- PRE TESTS
- Test groups: 5 male and 5 female guinea pigs.
Intradermal Induction
- Concentration selection: the concentration for the intradermal injections was selected on account of the solubility of the test article in standard vehicles and its local and systemic tolerability in a pretest.
- Concentration: 5 % in physiological saline (w/v). Since 5 % test item in physiological saline could be injected and was well tolerated, this concentration was used for the intradermal induction.
Epidermal Applications (induction and challenge)
- Concentration selection: the concentrations for the epidermal applications were selected on account of the primary irritation potential of the test article.
- Concentrations: 10, 20, 30, and 50 % in vaseline. 50 % in vaseline was the highest possible concentration of the test article.
- Results: erythema reactions were observed with 20, 30, and 50 % test item in vaseline.
MAIN STUDY
A1. INDUCTION EXPOSURE - intradermal injections
- Exposure period: performed on test day 0.
- No. of exposures: three pairs of intradermal injections (0.1 ml per injection) were made simultaneously into the left and right side of the shaved neck of the test and control group animals.
- Test group: adjuvant/saline mixture 1:1 (v/v); 5 % of test item in physiological saline (w/v); 5 % of test item in the adjuvant/saline mixture (w/v).
- Control group: adjuvant/saline mixture 1:1 (v/v); adjuvant/saline mixture 1:1 (v/v); physiological saline.
A2. INDUCTION EXPOSURE - epidermal applications
- Exposure period: performed on test day 8th.
- No. of exposures: one application.
- Application: substance was incorporated in vaseline (w/w) and applied on a filterpaper patch to the neck of the animals (patch 2×4 cm)
- Substance amout: approx. 0.4 g per patch.
- Type of wrap: occluded administration.
- Exposure period: 48 hours.
- Test group: 50 % of test item in vaseline
- Control group: treated with the vehicle only.
B. CHALLENGE EXPOSURE
- Exposure period: performed on test day 21st.
- Application: the test and control group animals were tested on one flank with test item in vaseline (w/w) and on the other flank with the vehicle alone (patch 2×2 cm)
- Substance amout: approx. 0.2 g per patch.
- Type of wrap: occluded administration.
- Exposure period: 24 hours.
- Test group: 10 % of test item in vaseline
- Control group: treated with the vehicle only.
POSITIVE CONTROL
The sensitivity of the strainis checked once or twice a year with a known mild to moderate sensitiser, such as mercaptobenzothiazole, hexyl cinnamic aldehyde or potassiumdichromate.
OBSERVATIONS
After the intradermal and the epidermal induction application irritant reactions are normally induced by the adjuvant and the high test article concentration. Because most of reactions are treatment related and not compound related, the reactions are only described in special cases in the section of results.
24 and 48 hours after removing the dressings, the challenge reactions were graded according to the Draize scoring scale.
The body weight was recorded at start and end of the test.
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5 % of test item, intradermal induction
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5 % of test item, intradermal induction
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
Any other information on results incl. tables
Number of positive animals per group after occlusive epidermal application
after 24 hours | after 48 hours | |
Control group | ||
Vehicle control | 0/10 | 0/10 |
Test article | 0/10 | 0/10 |
Test group | ||
Vehicle control | 0/20 | 0/20 |
Test article | 0/20 | 0/20 |
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified, according to the CLP Regulation (EC 1272/2008)
- Conclusions:
- Non skin sensitising.
- Executive summary:
Method
Skin-sensitising potential of was assessed in guinea pig maximisation test, using 10 males and 10 females as test group. Intradermal injections was performed at day 0 with 5 % w/v test item in physiological saline and in the adjuvant/saline mixture; epidermal induction was performed at day 8 with 50 % test item in vaseline; challenge was carried out at day 21 with 10 % test item in vaseline by epidermal occlusive patch system.
Results
Under the experimental conditions, none of the animals of the test group showed skin reactions 24 and 48 hours after removing the dressings. Therefore, the test article is considered to be a non sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.